Thank You To Everyone Who Voted
We are excited to announce the winning donation distribution percentages for these three wonderful charities in honor of Multiple Myeloma Awareness Month!*
Voting closed at 11:59 PM March 31st, 2022.
We Are Your Trusted Pharmacy for Multiple Myeloma Patients
We have created an oncology pharmacy experience unlike any other in the industry, and because of this, we are a trusted partner for many multiple myeloma medications.
Onco360 dispenses these medications to treat Multiple Myeloma: Cyclophosphamide, Ninlaro®, Pomalyst®, Revlimid®, Thalomid®, and Xpovio®.
This list is a small portion of the comprehensive oncology medications Onco360 can provide. Contact your sales representative for a complete listing.
| Brand Name | Generic Name | Route of Administration |
| Alkeran | Melphalan | Oral/intravenous |
| Adriamycin | Doxorubicin | Intravenous |
| Belrapzo, Bendeka, Treandav | Bendamustine | Intravenous |
| Cytoxan | Cyclophosphamide | Oral/intravenous |
| Darzalex | Daratumumab | Injectable/intravenous |
| Decadron | Dexamethasone | Oral/intravenous |
| Deltasone | >Prednisone | Oral |
| Empliciti | Elotuzumab | Intravenous |
| Evomela | Melphalan | Intravenous |
| Kyprolis | Carfilzomib | Intravenous |
| *Ninlaro | Ixazomib | Oral |
| Platinol | Cisplatin | Intravenous |
| *Pomalyst | Pomalidomide | Oral |
| *Revlimid | Lenalidomide | Oral |
| *Thalomid | Thalidomide | Oral |
| Toposar | Etoposide | Intravenous |
| Velcade | Bortezomib | Injectable/intravenous |
| *Venclexta | Venetoclax | Oral |
| *Xpovio | Selinexo | Oral |
Rx Ordering Made Easy
Onco360 provides easy ordering via e-Prescribe, fax, or by phone, and all prescriptions are shipped free of charge.
e-Prescribe
Oncomed Dba Onco360 or
NPI# 1679618151
Call
*Onco360 donated 5% of the select multiple myeloma cancer product portfolio gross profits during the month of March 2022. The general public had the option to vote for one of three charities. The final donation amount, not exceeding $15,000 was split between the three charities, Be The Match, MMRF.org, and the Leukemia and Lymphoma Society based on the percentage split of votes.